A Benefit-Risk Assessment of Inhaled Long-Acting β2-Agonists in the Management of Obstructive Pulmonary Disease Milind P. SovaniChristopher I. WhaleAnne. E. Tattersfield Review Article 20 November 2012 Pages: 689 - 715
Comparative Tolerability of Drug Treatment for Nocturnal Enuresis in Children Dominik MüllerCharles C. RoehrPaul Eggert Review Article 20 November 2012 Pages: 717 - 727
Calculation of Doses of Drugs in Solution Daniel W. WheelerDionysios D. RemoundosDavid K. Menon Short Communication 20 November 2012 Pages: 729 - 734
Safety Related Drug-Labelling Changes Manfred HaubenLester Reich Original Research Article 20 November 2012 Pages: 735 - 744
Haematological Effects of Interferon-β-1a (Rebif®) Therapy in Multiple Sclerosis Peter RieckmannPaul O’ConnorEnrica Alteri Original Research Article 20 November 2012 Pages: 745 - 756